Business Context and Reporting Period
This Form 8-K Current Report is filed by Inogen, Inc. (INGN) on July 1, 2026. The filing discloses the appointment of a new Chief Operating Officer and the terms of his employment agreement, effective July 6, 2026.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and corporate governance.
Material Changes
The primary material change reported is the appointment of Andrew (Andy) Reding as Executive Vice President and Chief Operating Officer. Mr. Reding brings experience from Viant Medical and Hillrom Respiratory Health. No financial or operational changes are detailed in this report.
Guidance, Outlook, and Compensation Details
The filing outlines the specific compensatory arrangements for the new COO, effective July 6, 2026:
- Base Salary: $500,000 annually.
- Performance Bonus: Target of 70% of base salary ($350,000).
- Sign-on Bonus: $100,000 cash (repayable pro-rata if terminated for cause or resigned without good reason within two years).
- Legal Fees: $2,500 reimbursement.
- Equity Award: 130,000 Restricted Stock Units (RSUs) vesting one-third annually over three years. These are granted as independent inducement awards outside existing equity plans.
- Severance:
- Standard termination (without cause/good reason): 12 months of base salary and COBRA subsidy.
- Change of Control period termination: 24 months of base salary and COBRA subsidy.
Management commentary is limited to the announcement of the appointment. No specific risks, contingencies, or unusual items are disclosed beyond standard employment agreement terms.
Investor Verification Checklist
- Verify the impact of the $100,000 sign-on bonus and 130,000 RSUs on immediate and future share count dilution.
- Review the full text of the Employment and Severance Agreement (Exhibit 10.1) for specific definitions of "cause" and "good reason."
- Confirm the status of the 130,000 RSUs as "independent inducement awards" to ensure compliance with Nasdaq Rule 5635(c)(4).
- Monitor future 10-Q or 10-K filings for the actual financial impact of the new executive's compensation on operating expenses.